Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Region Hovedstadens forskningsportal Forside
Hjælp og OSS
Dansk
English
Forside
Hospitaler/afdelinger
Forskere
Publikationer
Aktiviteter
Priser
Søg efter ekspertise, navn eller tilknytning
Ali Asmar
MD PhD
,
Bispebjerg og Frederiksberg Hospital
,
Klinisk Fysiologisk/Nuklearmedicinsk Afd.
2014
2023
Publikationer pr. år
Vis
Fingeraftryk
Netværk
Publikationer
(39)
Lignende profiler
(6)
Fingeraftryk
Dyk ned i forskningsemnerne, hvor Ali Asmar er aktive. Disse emneetiketter kommer fra dennes persons arbejder. Sammen danner de et unikt fingerprint.
Sorter
Vægt
Alfabetisk
Keyphrases
Glucagon-like
100%
Glucose-dependent Insulinotropic Polypeptide
33%
Glucagon-like peptide-1 (GLP-1)
31%
Cardiac Output
31%
Healthy Individuals
27%
Renal Oxygenation
24%
Renal Hemodynamics
23%
Sodium Chloride
22%
Heart Rate
22%
Acute Effects
21%
Nephropathy
21%
Glucose Effect
21%
Central Hemodynamics
21%
Vasodilation
21%
Cholecystokinin
21%
Angiotensin II (Ang II)
20%
A1 Receptor
19%
Plasma Renin Activity
16%
Perfusion
15%
Adipose Tissue Blood Flow
14%
Adipose Tissue
14%
Type 2 Diabetic Patients
13%
Volume Expansion
13%
Blood Pressure Regulation
13%
Blood Pressure Lowering
12%
Insulin
12%
Stroke Volume
12%
Extracellular Volume
12%
Positron Emission Tomography-computed Tomography (PET-CT)
12%
Placebo
11%
Human Kidney
11%
Type 1 Diabetes Mellitus (T1DM)
11%
Abdominal Adipose Tissue
11%
Vasodilator
11%
Natriuresis
11%
Renal Plasma Flow
10%
Moderate Stress
10%
Renal Perfusion
10%
Richter Transformation
10%
Quantitative MRI
10%
Chronic Lymphocytic Leukemia
10%
Ethnic Effect
10%
Extraction Effect
10%
Sodium Chloride Intake
10%
Glucose-dependent Insulinotropic Polypeptide Receptor
10%
Type I Diabetes
10%
Causes of Deterioration
10%
18F-FDG Positron Emission Tomography
10%
Renoprotective Effect
10%
Thyroid Incidentaloma
10%
Medicine and Dentistry
Glucagon Like Peptide 1
84%
Infusion
43%
Gastric Inhibitory Polypeptide
31%
Kidney Blood Flow
23%
Nephropathy
21%
Adipose Tissue
21%
Vasodilatation
21%
Cholecystokinin
21%
Heart Output
16%
Magnetic Resonance Imaging
15%
Glucagon Like Peptide 1 Receptor
13%
Angiotensin II
13%
Extracellular Fluid
12%
Stroke Volume
11%
Secretion (Process)
11%
Patient with Type 2 Diabetes
11%
Kidney Plasma Flow
11%
Kidney Perfusion
10%
Capillary
10%
Richter's Transformation
10%
Salt Intake
10%
Multiparametric Magnetic Resonance Imaging
10%
Pathophysiology
10%
COVID-19
10%
Gastrin
10%
Deterioration
10%
B-Cell Chronic Lymphocytic Leukemia
10%
Positron Emission Tomography-Computed Tomography
10%
Fluid Shift
10%
Chronic Kidney Disease
10%
Tissue Metabolism
10%
Compartment Syndrome
10%
Fluorodeoxyglucose F 18
10%
Blood Pressure
10%
Ambulatory Blood Pressure
10%
Blood Pressure Reduction
10%
Glomerular Filtration Rate
10%
Adipose Tissue Blood Flow
9%
Sodium Intake
8%
Flight
8%
Artery Blood Flow
7%
Imaging Technique
7%
Functional Magnetic Resonance Imaging
7%
Disease
7%
Blood Flow
6%
Natriuresis
6%
Renal Artery
6%
Diabetes
6%
Fick Principle
5%
Meal
5%
Biochemistry, Genetics and Molecular Biology
Glucagon-Like Peptide-1
52%
Gastric Inhibitory Polypeptide
42%
Vasodilatation
31%
Blood Pressure
27%
Cholecystokinin
21%
Heart Output
20%
Plasma Renin Activity
19%
Adipose Tissue Blood Flow
14%
Blood Pressure Regulation
14%
Normal Human
12%
Natriuresis
12%
Liquid
12%
Secretion (Process)
11%
Metabolite
11%
Lower Body Negative Pressure
10%
Gastric Inhibitory Polypeptide Receptor
10%
Tissue Metabolism
10%
Mental Stress
10%
Gastrin
10%
Glucagon-Like Peptide 1 Receptor
10%
Receptor Agonists
10%
Hemodynamic
10%
Skeletal Muscle
10%
Fluid Shift
10%
Systolic Blood Pressure
10%
Blood Level
10%
Angiotensin
8%
Flight
7%
Aldosterone
6%
Sodium Urine Level
6%
Noradrenalin Blood Level
6%
Glucose Blood Level
5%
Renin-Angiotensin
5%
C-Peptide
5%
